HuMAB companies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HuMAB companies

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (567)	11/4/2003 11:27:25 AM
From: Icebrg	Read Replies (1) of 1022

NovImmune is a Medarex collaborator. Erik PRINCETON, N.J. and GENEVA, Switzerland, May 17 [2001] /PRNewswire/ -- Medarex, Inc. (Nasdaq: MEDX) and NovImmune SA today announced a collaboration for the development of fully human therapeutic antibodies. Medarex expects to use its UltiMAb(TM) Human Antibody Development System(SM) to generate antibodies to disease targets discovered by NovImmune.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next